BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Serban DE. Microbiota in Inflammatory Bowel Disease Pathogenesis and Therapy: Is It All About Diet? Nutr Clin Pract 2015;30:760-79. [DOI: 10.1177/0884533615606898] [Cited by in Crossref: 47] [Cited by in F6Publishing: 49] [Article Influence: 6.7] [Reference Citation Analysis]
Number Citing Articles
1 Marković KG, Grujović MŽ, Koraćević MG, Nikodijević DD, Milutinović MG, Semedo-Lemsaddek T, Djilas MD. Colicins and Microcins Produced by Enterobacteriaceae: Characterization, Mode of Action, and Putative Applications. Int J Environ Res Public Health 2022;19:11825. [PMID: 36142096 DOI: 10.3390/ijerph191811825] [Reference Citation Analysis]
2 Liu G, Zhuo X, Huang Y, Liu H, Wu R, Kuo C, Chen N, Chuang L, Lin S, Chen Y, Yang H, Lee T. Alterations in Gut Microbiota and Upregulations of VPAC2 and Intestinal Tight Junctions Correlate with Anti-Inflammatory Effects of Electroacupuncture in Colitis Mice with Sleep Fragmentation. Biology 2022;11:962. [DOI: 10.3390/biology11070962] [Reference Citation Analysis]
3 Xia P, Hou T, Ma M, Li S, Jin H, Luo X, Li J, Geng F, Li B. Konjac oligosaccharides attenuate DSS-induced ulcerative colitis in mice: mechanistic insights. Food Funct 2022;13:5626-39. [PMID: 35506498 DOI: 10.1039/d1fo04004a] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
4 陈 雅. Screening and Evaluation of Probiotics for Reducing Intestinal Inflammation. HJFNS 2022;11:44-55. [DOI: 10.12677/hjfns.2022.111006] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Martyniak A, Medyńska-Przęczek A, Wędrychowicz A, Skoczeń S, Tomasik PJ. Prebiotics, Probiotics, Synbiotics, Paraprobiotics and Postbiotic Compounds in IBD. Biomolecules 2021;11:1903. [PMID: 34944546 DOI: 10.3390/biom11121903] [Cited by in Crossref: 11] [Cited by in F6Publishing: 15] [Article Influence: 11.0] [Reference Citation Analysis]
6 Di Re A, Liang Y, Gosselink MP, Ctercteko G. Acute Gastroenteritis in the Etiology of Inflammatory Bowel Disease: Systematic Review and Meta-analysis. Crohn's & Colitis 360 2021;3:otab065. [DOI: 10.1093/crocol/otab065] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Cruz-Lebrón A, D'argenio Garcia L, Talla A, Joussef-Piña S, Quiñones-Mateu ME, Sékaly RP, de Carvalho KIL, Levine AD. Decreased Enteric Bacterial Composition and Diversity in South American Crohn's Disease Vary With the Choice of Treatment Strategy and Time Since Diagnosis. J Crohns Colitis 2020;14:791-800. [PMID: 31758685 DOI: 10.1093/ecco-jcc/jjz189] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
8 Zeng W, He D, Xing Y, Liu J, Su N, Zhang C, Wang Y, Xing X. Internal connections between dietary intake and gut microbiota homeostasis in disease progression of ulcerative colitis: a review. Food Science and Human Wellness 2021;10:119-30. [DOI: 10.1016/j.fshw.2021.02.016] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 11.0] [Reference Citation Analysis]
9 Trivedi MK, Jana S. Evaluation of Anti-oxidation and Therapeutic Effect of Biofield Energy Healing Based Novel Test Formulation Using TNBS (Tri Nitro Benzene Sulfonic Acid) - Induced Ulcerative Colitis in Sprague Dawley Rats. JAA 2021;2:29-40. [DOI: 10.14302/issn.2471-2140.jaa-21-3704] [Reference Citation Analysis]
10 Zhuang X, Liu C, Zhan S, Tian Z, Li N, Mao R, Zeng Z, Chen M. Gut Microbiota Profile in Pediatric Patients With Inflammatory Bowel Disease: A Systematic Review. Front Pediatr 2021;9:626232. [PMID: 33604319 DOI: 10.3389/fped.2021.626232] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 14.0] [Reference Citation Analysis]
11 Vona R, Pallotta L, Cappelletti M, Severi C, Matarrese P. The Impact of Oxidative Stress in Human Pathology: Focus on Gastrointestinal Disorders. Antioxidants (Basel) 2021;10:201. [PMID: 33573222 DOI: 10.3390/antiox10020201] [Cited by in Crossref: 19] [Cited by in F6Publishing: 25] [Article Influence: 19.0] [Reference Citation Analysis]
12 Antunes C, Dziadkowiec K, Charabaty A. Advances in Our Understanding of the Pathogenesis of Inflammatory Bowel Disease. Clinical Gastroenterology 2021. [DOI: 10.1007/978-3-030-81780-0_1] [Reference Citation Analysis]
13 Hartzler ML, Castle L, Lewis C, Zakaria L. A functional approach to the chronic disease epidemic. Am J Health Syst Pharm 2020;77:668-72. [PMID: 32236457 DOI: 10.1093/ajhp/zxaa032] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
14 Cheng X, Zheng J, Lin A, Xia H, Zhang Z, Gao Q, Lv W, Liu H. A review: Roles of carbohydrates in human diseases through regulation of imbalanced intestinal microbiota. Journal of Functional Foods 2020;74:104197. [DOI: 10.1016/j.jff.2020.104197] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
15 Tang W, Huang Y, Shi P, Wang Y, Zhang Y, Xue A, Tang Z, Hu W, Sun H, Zhang P, Zheng C, Shi J, Wang S, Qiu X, Lu X, Miao S, Meng Y. Effect of Exclusive Enteral Nutrition on the Disease Process, Nutrition Status, and Gastrointestinal Microbiota for Chinese Children With Crohn's Disease. JPEN J Parenter Enteral Nutr 2021;45:826-38. [PMID: 32510616 DOI: 10.1002/jpen.1938] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
16 Milton DL, Johnson TW, Johnson K, Murphy B, Carter H, Hurt RT, Mundi MS, Epp L, Spurlock AY, Hussey J. Accepted Safe Food‐Handling Procedures Minimizes Microbial Contamination of Home‐Prepared Blenderized Tube‐Feeding. Nutrition in Clinical Practice 2020;35:479-86. [DOI: 10.1002/ncp.10450] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 9.0] [Reference Citation Analysis]
17 Sonnenberg A, Turner KO, Genta RM. Upper Gastrointestinal Disease Influences the Occurrence of Inflammatory Bowel Disease. Dig Dis Sci 2020;65:2373-8. [PMID: 31776861 DOI: 10.1007/s10620-019-05972-1] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
18 Seth RK, Maqsood R, Mondal A, Bose D, Kimono D, Holland LA, Janulewicz Lloyd P, Klimas N, Horner RD, Sullivan K, Lim ES, Chatterjee S. Gut DNA Virome Diversity and Its Association with Host Bacteria Regulate Inflammatory Phenotype and Neuronal Immunotoxicity in Experimental Gulf War Illness. Viruses 2019;11:E968. [PMID: 31640184 DOI: 10.3390/v11100968] [Cited by in Crossref: 27] [Cited by in F6Publishing: 29] [Article Influence: 9.0] [Reference Citation Analysis]
19 Parolini C. Effects of Fish n-3 PUFAs on Intestinal Microbiota and Immune System. Mar Drugs 2019;17:E374. [PMID: 31234533 DOI: 10.3390/md17060374] [Cited by in Crossref: 58] [Cited by in F6Publishing: 63] [Article Influence: 19.3] [Reference Citation Analysis]
20 Heshmati K, Lo T, Tavakkoli A, Sheu E. Short-Term Outcomes of Inflammatory Bowel Disease after Roux-en-Y Gastric Bypass vs Sleeve Gastrectomy. Journal of the American College of Surgeons 2019;228:893-901.e1. [DOI: 10.1016/j.jamcollsurg.2019.01.021] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 5.3] [Reference Citation Analysis]
21 Zhuang L, Chen H, Zhang S, Zhuang J, Li Q, Feng Z. Intestinal Microbiota in Early Life and Its Implications on Childhood Health. Genomics Proteomics Bioinformatics 2019;17:13-25. [PMID: 30986482 DOI: 10.1016/j.gpb.2018.10.002] [Cited by in Crossref: 97] [Cited by in F6Publishing: 102] [Article Influence: 32.3] [Reference Citation Analysis]
22 Moutinho BD, Baima JP, Rigo FF, Saad-Hossne R, Rodrigues J, Romeiro FG, Sassaki LY. Fecal microbiota transplantation in refractory ulcerative colitis - a case report. J Int Med Res 2019;47:1072-9. [PMID: 30632438 DOI: 10.1177/0300060518821790] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
23 Johnson TW, Milton DL, Johnson K, Carter H, Hurt RT, Mundi MS, Epp L, Spurlock AL. Comparison of Microbial Growth Between Commercial Formula and Blenderized Food for Tube Feeding. Nutrition in Clinical Practice 2019;34:257-63. [DOI: 10.1002/ncp.10226] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 5.8] [Reference Citation Analysis]
24 Sood A, Mahajan R, Juyal G, Midha V, Grewal CS, Mehta V, Singh A, Joshi MC, Narang V, Kaur K, Sidhu H. Efficacy of fecal microbiota therapy in steroid dependent ulcerative colitis: a real world intention-to-treat analysis. Intest Res 2019;17:78-86. [PMID: 30449078 DOI: 10.5217/ir.2018.00089] [Cited by in Crossref: 34] [Cited by in F6Publishing: 35] [Article Influence: 8.5] [Reference Citation Analysis]
25 Wang S, Lin Y, Yuan X, Li F, Guo L, Wu B. REV-ERBα integrates colon clock with experimental colitis through regulation of NF-κB/NLRP3 axis. Nat Commun 2018;9:4246. [PMID: 30315268 DOI: 10.1038/s41467-018-06568-5] [Cited by in Crossref: 120] [Cited by in F6Publishing: 131] [Article Influence: 30.0] [Reference Citation Analysis]
26 Shi Y, Zhou J, Jiang B, Miao M. Resveratrol and inflammatory bowel disease. Ann N Y Acad Sci 2017;1403:38-47. [PMID: 28945937 DOI: 10.1111/nyas.13426] [Cited by in Crossref: 28] [Cited by in F6Publishing: 33] [Article Influence: 5.6] [Reference Citation Analysis]
27 Zhang M, Sun K, Wu Y, Yang Y, Tso P, Wu Z. Interactions between Intestinal Microbiota and Host Immune Response in Inflammatory Bowel Disease. Front Immunol 2017;8:942. [PMID: 28855901 DOI: 10.3389/fimmu.2017.00942] [Cited by in Crossref: 170] [Cited by in F6Publishing: 182] [Article Influence: 34.0] [Reference Citation Analysis]
28 Gatti S, Galeazzi T, Franceschini E, Annibali R, Albano V, Verma AK, De Angelis M, Lionetti ME, Catassi C. Effects of the Exclusive Enteral Nutrition on the Microbiota Profile of Patients with Crohn's Disease: A Systematic Review. Nutrients. 2017;9:832. [PMID: 28777338 DOI: 10.3390/nu9080832] [Cited by in Crossref: 39] [Cited by in F6Publishing: 39] [Article Influence: 7.8] [Reference Citation Analysis]
29 Zeitz J, Bissig M, Barthel C, Biedermann L, Scharl S, Pohl D, Frei P, Vavricka SR, Fried M, Rogler G, Scharl M. Patients' views on fecal microbiota transplantation: an acceptable therapeutic option in inflammatory bowel disease? Eur J Gastroenterol Hepatol. 2017;29:322-330. [PMID: 27879485 DOI: 10.1097/meg.0000000000000783] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 2.6] [Reference Citation Analysis]
30 Oxelmark L, Lindberg A, Löfberg R, Sternby B, Eriksson A, Almer S, Befrits R, Fossum B, Karlén P, Broström O, Tysk C; SOIBD, the Swedish Organization for the study of Inflammatory Bowel Disease. Use of complementary and alternative medicine in Swedish patients with inflammatory bowel disease: a controlled study. Eur J Gastroenterol Hepatol 2016;28:1320-8. [PMID: 27472271 DOI: 10.1097/MEG.0000000000000710] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 3.2] [Reference Citation Analysis]
31 Ganji-Arjenaki M, Rafieian-Kopaei M. Probiotics are a good choice in remission of inflammatory bowel diseases: A meta analysis and systematic review. J Cell Physiol. 2018;233:2091-2103. [PMID: 28294322 DOI: 10.1002/jcp.25911] [Cited by in Crossref: 166] [Cited by in F6Publishing: 172] [Article Influence: 33.2] [Reference Citation Analysis]
32 Uygun A, Ozturk K, Demirci H, Oger C, Avci IY, Turker T, Gulsen M. Fecal microbiota transplantation is a rescue treatment modality for refractory ulcerative colitis. Medicine (Baltimore) 2017;96:e6479. [PMID: 28422836 DOI: 10.1097/MD.0000000000006479] [Cited by in Crossref: 40] [Cited by in F6Publishing: 42] [Article Influence: 8.0] [Reference Citation Analysis]
33 Thomas S, Izard J, Walsh E, Batich K, Chongsathidkiet P, Clarke G, Sela DA, Muller AJ, Mullin JM, Albert K, Gilligan JP, DiGuilio K, Dilbarova R, Alexander W, Prendergast GC. The Host Microbiome Regulates and Maintains Human Health: A Primer and Perspective for Non-Microbiologists. Cancer Res 2017;77:1783-812. [PMID: 28292977 DOI: 10.1158/0008-5472.CAN-16-2929] [Cited by in Crossref: 181] [Cited by in F6Publishing: 190] [Article Influence: 36.2] [Reference Citation Analysis]
34 Khan I, Samson SE, Grover AK. Antioxidant Supplements and Gastrointestinal Diseases: A Critical Appraisal. Med Princ Pract 2017;26:201-17. [PMID: 28278495 DOI: 10.1159/000468988] [Cited by in Crossref: 28] [Cited by in F6Publishing: 31] [Article Influence: 5.6] [Reference Citation Analysis]
35 Smolinska A, Bodelier AG, Dallinga JW, Masclee AA, Jonkers DM, van Schooten FJ, Pierik MJ. The potential of volatile organic compounds for the detection of active disease in patients with ulcerative colitis. Aliment Pharmacol Ther 2017;45:1244-54. [PMID: 28239876 DOI: 10.1111/apt.14004] [Cited by in Crossref: 29] [Cited by in F6Publishing: 29] [Article Influence: 5.8] [Reference Citation Analysis]
36 Krentz T, Allen S. Bacterial translocation in critical illness. J Small Anim Pract 2017;58:191-8. [PMID: 28186322 DOI: 10.1111/jsap.12626] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 2.6] [Reference Citation Analysis]
37 Flier LC, Welstead LA. Nutrition Matters in IBD. Clinical Gastroenterology 2017. [DOI: 10.1007/978-3-319-53763-4_14] [Reference Citation Analysis]
38 Moura FA, Goulart MOF. Inflammatory Bowel Diseases. Gastrointestinal Tissue. Elsevier; 2017. pp. 99-112. [DOI: 10.1016/b978-0-12-805377-5.00007-2] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
39 Rahmouni O, Dubuquoy L, Desreumaux P, Neut C. Microbiote intestinal et développement des maladies inflammatoires chroniques de l’intestin. Med Sci (Paris) 2016;32:968-73. [DOI: 10.1051/medsci/20163211012] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
40 Molina-Infante J, Schoepfer AM, Lucendo AJ, Dellon ES. Eosinophilic esophagitis: What can we learn from Crohn's disease? United European Gastroenterol J 2017;5:762-72. [PMID: 29026590 DOI: 10.1177/2050640616672953] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 2.7] [Reference Citation Analysis]
41 Geng X, Xue J. Expression of Treg/Th17 cells as well as related cytokines in patients with inflammatory bowel disease. Pak J Med Sci. 2016;32:1164-1168. [PMID: 27882014 DOI: 10.12669/pjms.325.10902] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
42 Varanat M, Haase EM, Kay JG, Scannapieco FA. Activation of the TREM-1 pathway in human monocytes by periodontal pathogens and oral commensal bacteria. Mol Oral Microbiol 2017;32:275-87. [PMID: 27448788 DOI: 10.1111/omi.12169] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 2.8] [Reference Citation Analysis]
43 Dolan KT, Chang EB. Diet, gut microbes, and the pathogenesis of inflammatory bowel diseases. Mol Nutr Food Res 2017;61. [PMID: 27346644 DOI: 10.1002/mnfr.201600129] [Cited by in Crossref: 64] [Cited by in F6Publishing: 74] [Article Influence: 10.7] [Reference Citation Analysis]
44 Yang H, Lee Y. Seaweed Derived Oligosaccharides and its Health Beneficial Effects on Gut Health. The Journal of the Korea Contents Association 2016;16:465-475. [DOI: 10.5392/jkca.2016.16.07.465] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
45 Debebe T, Holtze S, Morhart M, Hildebrandt TB, Rodewald S, Huse K, Platzer M, Wyohannes D, Yirga S, Lemma A, Thieme R, König B, Birkenmeier G. Analysis of cultivable microbiota and diet intake pattern of the long-lived naked mole-rat. Gut Pathog 2016;8:25. [PMID: 27239229 DOI: 10.1186/s13099-016-0107-3] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
46 Yadav V, Varum F, Bravo R, Furrer E, Bojic D, Basit AW. Inflammatory bowel disease: exploring gut pathophysiology for novel therapeutic targets. Transl Res 2016;176:38-68. [PMID: 27220087 DOI: 10.1016/j.trsl.2016.04.009] [Cited by in Crossref: 105] [Cited by in F6Publishing: 108] [Article Influence: 17.5] [Reference Citation Analysis]
47 Wang M, Monaco MH, Donovan SM. Impact of early gut microbiota on immune and metabolic development and function. Semin Fetal Neonatal Med 2016;21:380-7. [PMID: 27132110 DOI: 10.1016/j.siny.2016.04.004] [Cited by in Crossref: 64] [Cited by in F6Publishing: 69] [Article Influence: 10.7] [Reference Citation Analysis]
48 Sobolewska-Włodarczyk A, Włodarczyk M, Szemraj J, Stec-Michalska K, Fichna J, Wiśniewska-Jarosińska M. Circadian rhythm abnormalities - Association with the course of inflammatory bowel disease. Pharmacol Rep 2016;68:847-51. [PMID: 27166084 DOI: 10.1016/j.pharep.2016.04.007] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 3.5] [Reference Citation Analysis]